NEOS THERAPEUTICS, INC.

Profile

Company Names

NEOS THERAPEUTICS, INC.

Addresses

2940 N. HIGHWAY 360, GRAND PRAIRIE, TX 75050

2940 N. HIGHWAY 360, SUITE 400, GRAND PRAIRIE, TX 75050

2940 N. HIGHWAY 360, SUITE 100, GRAND PRAIRIE, TX 75050

Phone Numbers

972.408.1300
972.408.1360

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2009

State Incorporated:

TEXAS

Total Amount Raised:

$94,641,920.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2014-12-30 
$20,624,355.00 
$20,624,355.00 
$0.00 
Equity 
5
2014-03-28 
$2,500,000.00 
$2,500,000.00 
$0.00 
Equity 
4
2013-12-19 
$15,500,170.00 
$15,500,170.00 
$0.00 
Equity 
3
2012-07-02 
$18,267,890.00 
$30,000,000.00 
$11,732,110.00 
Equity 
2
2011-05-27 
$13,554,505.00 
$20,000,000.00 
$6,445,495.00 
Equity 
1
2009-06-19 
$24,195,000.00 
$50,000,000.00 
$25,805,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARGARET 
 
CABANO 
EXECUTIVE OFFICER
CHRIS 
 
CLEMENT 
DIRECTOR
CHRISTOPHER 
 
CLEMENT 
DIRECTOR
RICHARD 
 
EISENSTADT 
EXECUTIVE OFFICER
DOROTHY 
 
ENGELKING 
EXECUTIVE OFFICER
ARLEN 
 
EWART 
EXECUTIVE OFFICER
DOROTHY 
 
FRANK 
EXECUTIVE OFFICER
VIPIN 
 
GARG 
DIRECTOR, EXECUTIVE OFFICER
ALAN 
 
HELLER 
DIRECTOR
BRYAN 
 
HILL 
EXECUTIVE OFFICER
ELLEN 
 
HOFFING 
EXECUTIVE OFFICER
RALPH 
 
IANNELLI 
DIRECTOR
MARGARET 
 
LOKASH 
EXECUTIVE OFFICER
STEVEN 
 
LUTZ 
EXECUTIVE OFFICER
RUSS 
 
MCMAHEN 
EXECUTIVE OFFICER
VICTOR 
 
MILLER 
EXECUTIVE OFFICER
ASIF 
 
MUGHAL 
EXECUTIVE OFFICER
GREG 
 
ROBITAILLE 
DIRECTOR
EDWARD 
 
SCHNIPPER 
DIRECTOR
CAROLYN 
 
SIKES 
EXECUTIVE OFFICER
STACIE 
 
SWITZER 
EXECUTIVE OFFICER
MARK 
 
TENGLER 
EXECUTIVE OFFICER
MARK 
 
VAN AUSDAL 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-30 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-30 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-28 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-19 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-19 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-27 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-19 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-19 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-19 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
SALEM PARTNERS LLC